Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

Carboxytherapy is a safe and effective treatment for improving skin appearance and treating various skin conditions, with mild side effects.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Children with darker skin tones can have specific skin conditions that need tailored treatments.

PRP and cell therapies may help with hair loss, but more research is needed.

Tinea capitis should be considered in adults with scalp issues for proper treatment.

Using topical minoxidil for baldness can cause heart problems, especially in those with heart disease.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

The study found that using 2% minoxidil solution can help grow hair and is safe.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Flutamide rarely causes liver toxicity in prostate cancer patients.

The conclusion is that genetic differences affect how the cochlea heals after hair cell loss, which may challenge the creation of hearing loss treatments.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Trichoscopy is better than trichogram for diagnosing female hair loss.

Trichoscopy is a useful tool for diagnosing hair and scalp issues, but doctors must be careful to avoid mistakes.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Methionine restriction works better than betaine for treating CBS deficiency symptoms in mice.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Dermoscopy helped diagnose discoid lupus erythematosus in two patients without needing skin biopsies.